HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by WINKEL, C. A. Articles by DOYLE, L. Search for Related Content PubMed PubMed Citation Articles by WINKEL, C. A. Articles by DOYLE, L.

A Clinical Study of the Inhiband

From the Department of Obstetrics and Gynecology, Tulane Medical School, New Orleans, La.

Abstract

Inhibands were inserted into 236 parous women who were followed for a 2-year period. During the study, 46 women underwent elective hysterectomy and 41 patients were lost to followup; thus, the data are not suitable for the preferred life table method of analysis. Pregnancy occurred in 25 patients, expulsion in 14 and the device had to be removed for medical reasons in 53. One perforation occurred 6 months after insertion, and in 11 of 24 specimens examined at hysterectomy, the device was embedded, usually in the lower uterine segment. Side effects, such as bleeding and cramping, were reported by over 50% of the patients during the study. The incidence of serious problems, such as pregnancy, embedding and inability to remove the device, probably due to embedding, increased with time.